Warning - Corporate Compensation Clawbacks Are Coming!
October 19, 2023, 12:17 PM
By: Daniel K. Oakes
On October 4, 2023, Deputy Attorney General Lisa O. Monaco announced a new "safe harbor" policy for voluntary self-disclosures in the context of mergers and acquisitions, whereby the Department of Justice will decline to prosecute companies that report criminal misconduct involving recently-acquired businesses. This news made antitrust headlines, and for good reason. The new policy furthers the DOJ's push for increased voluntary self-disclosure, akin to its cartel enforcement Leniency Program. But a second, less widely-emphasized, aspect of Monaco's speech also seems poised to impact everyday compliance—indeed, the very design of corporate compliance programs—going forward.
For several years, the DOJ has sought to deter criminal conduct by incentivizing the implementation of more effective corporate compliance programs. In a September 2022 memorandum, the DOJ emphasized the novel approach that, in assessing the effectiveness of a compliance program and corporate culture, prosecutors would consider whether the firm adopted compensation systems that impose financial penalties on executives and employees who engage in misconduct. To push this policy further, the DOJ launched a new pilot program in March 2023 that rewarded companies that implemented clawback measures and sought recoupment of compensation from culpable individuals.
Ms. Monaco's recent speech notably extolled the early successes of this pilot program. Indeed, the DOJ touted two recent resolutions that included compensation incentive overhauls or clawbacks: Albemarle and Corficolombiana. The DOJ expects to see further supportive results because the pilot now requires that every Criminal Division resolution include compliance-related criteria in compensation and bonus systems, with reporting obligations to the government about the implementation of these measures.
The takeaway is unmistakable: a once seemingly radical suggestion is now likely to become the corporate compliance standard. The DOJ will soon expect companies to have enacted compliance-promoting compensation policies long before they come under criminal investigation. To maximize the benefits of a thoughtful corporate compliance program in all aspects of a corporate resolution—from charging decisions to fining to compliance terms—companies ought to reconsider their policies now with an eye toward further incentivizing employees, executives, and directors to avoid suspect behaviors, rather than shift the costs of their misconduct to shareholders.
Under the pilot program, every Criminal Division resolution now requires companies to add compliance-promoting criteria to their compensation systems. These criteria are tailored to the company’s existing compensation system to ensure integration with its compliance program. . . . The pilot program also rewards companies that claw back or withhold incentive compensation from executives responsible for misconduct – or attempt to do so in good faith. For every dollar that a company claws back or withholds from an employee who engaged in misconduct – or a supervisor that knew of or turned a blind eye to it – the Department will deduct a dollar from the otherwise applicable penalty that the resolving company would pay.

To subscribe to our publications, click here.
News & Insights
News & Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
